Author: Prodeon Medical

Prodeon Medical Announces First Commercial Case of the Urocross® Expander System

October 16, 2026
Prodeon Medical Receives FDA 510(k) Clearance for the Urocross® Expander System, a Novel Non-Permanent Retrievable Implant for Treating Urinary Symptoms Associated with Benign Prostatic Hyperplasia

March 16, 2026

Prodeon Medical Announces First Commercial Case of the Urocross® Expander System